Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

Eva Boysen Fynboe Ebert, Tine McCulloch, Karin Holmskov Hansen, Hanne Linnet, Boe Sorensen, Peter Meldgaard

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

20 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science